SkinBioTherapeutics plc (AIM: SBTX), a life science group focused on skin health, has confirmed the final results of its WRAP Retail Offer, completing a broader £4.2 million fundraising effort at an issue price of 17 pence per share.
The WRAP Retail Offer raised gross proceeds of approximately £0.1 million, with 587,191 new ordinary shares to be issued to participating retail investors. This announcement follows the company’s earlier announcement on June 16, 2025.
Combined with the previously announced placing and subscription, which raised the bulk of the funds through the issue of 24,117,645 shares, the total gross proceeds raised by SkinBioTherapeutics amount to approximately £4.2 million.
The new funding will enable SkinBioTherapeutics to advance its pipeline of skin health therapies and continue progressing its research and commercialisation strategy.
Investor presentation
Now that the Open Offer has been closed, SkinBioTherapeutics will organising a presentation for shareholders, via the Investor Meet Company platform, in the week commencing 30 June 2025. The presentation will be open to all existing and potential SkinBioTherapeutics shareholders.
Once the timing of the presentation has been finalised, investors who already follow SkinBioTherapeutics on the Investor Meet Company platform will automatically be invited. Investors can sign up to Investor Meet Company for free Here.
For further information, please contact:
|
SkinBioTherapeutics plc |
+44 (0) 191 495 7325 |
